Introduction
============

Despite FMF is considered an autosomal recessive disease caused by mutations of *MEFV*, one third of patients carries one mutation only.

Aim
===

To analyze the actual impact of MEFV mutations in children with periodic fever.

Methods
=======

113 caucasian patients carrying MEFV mutations (46 with mutations in two alleles, 67 heterozygous) and 205 genetically negative patients for MEFV, TNFSF1A and MEFV (70% with a PFAPA phenotype) were analyzed. The following groups were considerd: patients with: i) 2 high penetrance mutations (M694V, M694I, M680I), ii) 1 high, 1 low penetrance mutation, iii) 2 low penetrance mutations, iv) 1 high penetrance mutation, v) one low penetrance mutation, vi) genetically negative.

Results
=======

Patients with two mutations displayed a higher prevalence of chest pain (p = 0.001), pleurisy (p = 0.003) and severe abdominal pain (p = 0.002) in respect to heterozygous patients, which clinical phenotype was more similar to that presented by genetically negative patients, with an higher prevalence of erythematous (p = 0.01) and exudative ( p = 0.009) pharyngitis, enlarged cervical lymph nodes (p = 0.002). The frequency of "FMF-like symptoms" decreases from patients carrying two high penetrance mutations towards patients with a single low penetrance mutation with a specular increase of "PFAPA-like symptoms" (Figure [1](#F1){ref-type="fig"}).
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Conclusions
===========

The present study shows a dosage effect of MEFV mutations not consistent with a pure autosomal recessive disorder. A dominant negative or gain of function effects or variants of still unidentified modifier genes may influence the presence of a FMF phenotype in heterozygous patients.
